Acadia Pharmaceuticals (ACAD) PT Raised to $23 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $23.00 (from $18.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
